Save time and get answers to complex questions with AI chat
When does guselkumab patent expire?Drugpatentwatch market analysis industry today?Chlorpheniramine cost?Drug patent watch trametinib?The expiration date of the key patent for guselkumab?
Pneumovax 23 (the 23-valent pneumococcal polysaccharide vaccine) is made by Merck & Co., Inc. (also known as MSD outside the U.S.)—it is marketed as Pneumovax 23 in the United States.
Yes, it is a pneumococcal vaccine but it is different from newer pneumococcal conjugate vaccines (like PCV13 and PCV20/PCV21). Pneumovax 23 is specifically the 23-valent polysaccharide formulation.
For manufacturer and other product details tied to patents and market exclusivity, you can also check DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Pneumovax :